Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q88993397 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000219.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q88993397 | ||
024 | ‡a 0000-0002-0909-2963 ‡2 orcid | ||
035 | ‡a (OCoLC)Q88993397 | ||
100 | 0 | ‡a D-Y Wang ‡c researcher ‡9 en | |
400 | 0 | ‡a D-Y Wang ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's A compendium answering 150 questions on COVID-19 and SARS-CoV-2 | ||
670 | ‡a Author's Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties | ||
670 | ‡a Author's Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma | ||
670 | ‡a Author's Do NERDy eosinophils accelerate nasal polyp growth? | ||
670 | ‡a Author's Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia | ||
670 | ‡a Author's Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care | ||
670 | ‡a Author's HIF-1α induces NLRP3 expression by M1 macrophages in non-eosinophilic chronic rhinosinusitis with nasal polyps | ||
670 | ‡a Author's Infiltration pattern of gammadelta T cells and its association with local inflammatory response in the nasal mucosa of patients with allergic rhinitis | ||
670 | ‡a Author's Novel findings in immunopathophysiology of chronic rhinosinusitis and their role in a model of precision medicine | ||
670 | ‡a Author's Precision medicine in united airways disease: A "treatable traits" approach | ||
670 | ‡a Author's Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of northern China. | ||
670 | ‡a Author's Recent developments and highlights in rhinitis and allergen immunotherapy | ||
670 | ‡a Author's Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis | ||
670 | ‡a Author's Role of IL-13Rα2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa | ||
670 | ‡a Author's Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type-2 inflammation | ||
670 | ‡a Author's Role of microRNAs in inflammatory upper airway diseases | ||
670 | ‡a Author's Role of Yes-associated protein in Interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps | ||
670 | ‡a Author's The hippo pathway effector YAP promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps | ||
670 | ‡a Author's The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling | ||
670 | ‡a Author's Update about Oralair® as a treatment for grass pollen allergic rhinitis | ||
670 | ‡a Author's Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations | ||
670 | ‡a Author's Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives | ||
670 | ‡a Author's Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps | ||
909 | ‡a (orcid) 0000000209092963 ‡9 1 | ||
912 | ‡a rhinitisassociatedwithasthmaisdistinctfromrhinitisalonethescpariamedallscphypothesis ‡A Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis ‡9 1 | ||
919 | ‡a hippopathwayeffectoryappromotesepithelialproliferationandremodelinginchronicrhinosinusitiswithnasalpolyps ‡A The hippo pathway effector YAP promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps ‡9 1 | ||
919 | ‡a microdissectedgeneexpressionlandscapeofnasopharyngealcancerrevealsvulnerabilitiesinfgfandnoncanonicalnfκbsignaling ‡A The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling ‡9 1 | ||
919 | ‡a usingpatientprofilestoguidethechoiceofantihistaminesintheprimarycaresettinginmalaysiaexpertconsensusandrecommendations ‡A Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations ‡9 1 | ||
919 | ‡a vaccinesandallergicreactionsthepastthecurrentcovid19pandemicandfutureperspectives ‡A Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives ‡9 1 | ||
919 | ‡a wholetranscriptomesequencingrevealsheightenedinflammationanddefectivehostdefenceresponsesinchronicrhinosinusitiswithnasalpolyps ‡A Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps ‡9 1 | ||
919 | ‡a donerdyeosinophilsacceleratenasalpolypgrowth ‡A Do NERDy eosinophils accelerate nasal polyp growth? ‡9 1 | ||
919 | ‡a biomarkersfordiagnosisandpredictionoftherapyresponsesinallergicdiseasesandasthma ‡A Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma ‡9 1 | ||
919 | ‡a antihistaminesforallergicrhinitistreatmentfromtheviewpointofnonsedativeproperties ‡A Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties ‡9 1 | ||
919 | ‡a compendiumanswering150questionsoncovid19andsarscov2 ‡A A compendium answering 150 questions on COVID-19 and SARS-CoV-2 ‡9 1 | ||
919 | ‡a updateaboutoralairasatreatmentforgrasspollenallergicrhinitis ‡A Update about Oralair® as a treatment for grass pollen allergic rhinitis ‡9 1 | ||
919 | ‡a enteroviral3cproteaseactivatesthehumannlrp1inflammasomeinairwayepithelia ‡A Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia ‡9 1 | ||
919 | ‡a futureresearchtrendsinunderstandingthemechanismsunderlyingallergicdiseasesforimprovedpatientcare ‡A Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care ‡9 1 | ||
919 | ‡a hif1αinducesnlrp3expressionbym1macrophagesinnoneosinophilicchronicrhinosinusitiswithnasalpolyps ‡A HIF-1α induces NLRP3 expression by M1 macrophages in non-eosinophilic chronic rhinosinusitis with nasal polyps ‡9 1 | ||
919 | ‡a infiltrationpatternofgammadeltatcellsanditsassociationwithlocalinflammatoryresponseinthenasalmucosaofpatientswithallergicrhinitis ‡A Infiltration pattern of gammadelta T cells and its association with local inflammatory response in the nasal mucosa of patients with allergic rhinitis ‡9 1 | ||
919 | ‡a novelfindingsinimmunopathophysiologyofchronicrhinosinusitisandtheirroleinamodelofprecisionmedicine ‡A Novel findings in immunopathophysiology of chronic rhinosinusitis and their role in a model of precision medicine ‡9 1 | ||
919 | ‡a precisionmedicineinunitedairwaysdiseaseatreatabletraitsapproach ‡A Precision medicine in united airways disease: A "treatable traits" approach ‡9 1 | ||
919 | ‡a prevalenceofpolleninducedallergicrhinitiswithhighpollenexposureingrasslandsofnorthernchina ‡A Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of northern China. ‡9 1 | ||
919 | ‡a recentdevelopmentsandhighlightsinrhinitisandallergenimmunotherapy ‡A Recent developments and highlights in rhinitis and allergen immunotherapy ‡9 1 | ||
919 | ‡a roleofil13rα2inmodulatingil13inducedmuc5acandciliarychangesinhealthyandcrswnpmucosa ‡A Role of IL-13Rα2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa ‡9 1 | ||
919 | ‡a roleofil25il33andtslpintriggeringunitedairwaydiseasestowardtype2inflammation ‡A Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type-2 inflammation ‡9 1 | ||
919 | ‡a roleofmicrornasininflammatoryupperairwaydiseases ‡A Role of microRNAs in inflammatory upper airway diseases ‡9 1 | ||
919 | ‡a roleofyesassociatedproteinininterleukin13inducednasalremodelingofchronicrhinosinusitiswithnasalpolyps ‡A Role of Yes-associated protein in Interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps ‡9 1 | ||
996 | ‡2 NKC|xx0301222 | ||
996 | ‡2 DNB|1276447876 | ||
996 | ‡2 DNB|1060770350 | ||
996 | ‡2 LC|n 2016047450 | ||
996 | ‡2 J9U|987007362337505171 | ||
996 | ‡2 LC|n 86830770 | ||
996 | ‡2 CYT|AC000659453 | ||
996 | ‡2 ISNI|0000000037455472 | ||
996 | ‡2 PLWABN|9812443686405606 | ||
996 | ‡2 DNB|116914389X | ||
996 | ‡2 LC|n 84157110 | ||
996 | ‡2 LC|nr 95000156 | ||
996 | ‡2 ISNI|0000000403178912 | ||
996 | ‡2 LC|nr 90028540 | ||
996 | ‡2 DNB|1049959272 | ||
996 | ‡2 LC|n 2023066569 | ||
996 | ‡2 LC|n 2017012756 | ||
996 | ‡2 LC|n 2019000543 | ||
996 | ‡2 LC|no2009068811 | ||
996 | ‡2 ISNI|0000000444587536 | ||
996 | ‡2 DNB|1300350997 | ||
996 | ‡2 LC|no2016019577 | ||
996 | ‡2 CAOONL|ncf11868614 | ||
996 | ‡2 SZ|1236964306 | ||
996 | ‡2 CYT|AC000659697 | ||
996 | ‡2 LC|n 2012057797 | ||
996 | ‡2 DNB|132434718X | ||
996 | ‡2 LC|no2009054436 | ||
996 | ‡2 NTA|177050691 | ||
996 | ‡2 DNB|1094906484 | ||
996 | ‡2 CYT|AC000163577 | ||
996 | ‡2 LC|n 79113592 | ||
996 | ‡2 LC|no2010122788 | ||
996 | ‡2 NUKAT|n 2007134023 | ||
996 | ‡2 NKC|xx0124043 | ||
996 | ‡2 LC|n 2019043360 | ||
996 | ‡2 DNB|1053580126 | ||
996 | ‡2 J9U|987007323382405171 | ||
996 | ‡2 CAOONL|ncf10288780 | ||
996 | ‡2 ISNI|0000000408764283 | ||
996 | ‡2 ISNI|0000000050026015 | ||
996 | ‡2 LC|n 2009078916 | ||
996 | ‡2 ISNI|0000000082580010 | ||
996 | ‡2 J9U|987007324420605171 | ||
996 | ‡2 LC|nr2002012180 | ||
996 | ‡2 LC|no2015081643 | ||
996 | ‡2 DNB|1022836714 | ||
996 | ‡2 ISNI|000000006337756X | ||
996 | ‡2 LC|no2021133541 | ||
996 | ‡2 ISNI|0000000498858987 | ||
996 | ‡2 LC|no2016041492 | ||
996 | ‡2 CYT|AC000127170 | ||
996 | ‡2 ISNI|0000000049474806 | ||
996 | ‡2 LC|no2006109893 | ||
996 | ‡2 BNF|17082665 | ||
996 | ‡2 LC|no2023130640 | ||
996 | ‡2 ISNI|0000000082630954 | ||
996 | ‡2 SUDOC|12058591X | ||
996 | ‡2 ISNI|0000000486517544 | ||
996 | ‡2 CYT|AC000143593 | ||
996 | ‡2 DNB|139901582 | ||
996 | ‡2 DNB|1254182160 | ||
996 | ‡2 LC|n 2019056218 | ||
996 | ‡2 DNB|1307976662 | ||
996 | ‡2 ISNI|0000000075321184 | ||
996 | ‡2 DNB|128531137X | ||
996 | ‡2 ISNI|0000000041259095 | ||
996 | ‡2 ISNI|0000000049634830 | ||
996 | ‡2 CYT|AC000642080 | ||
996 | ‡2 LC|n 78048253 | ||
996 | ‡2 ISNI|0000000064351492 | ||
996 | ‡2 ISNI|0000000023267788 | ||
996 | ‡2 LC|n 2024027384 | ||
996 | ‡2 SUDOC|162291507 | ||
996 | ‡2 ISNI|0000000027828837 | ||
996 | ‡2 CYT|AC000161592 | ||
996 | ‡2 LC|n 84132735 | ||
996 | ‡2 ISNI|0000000444602433 | ||
996 | ‡2 LC|n 83024044 | ||
996 | ‡2 ISNI|0000000064080952 | ||
996 | ‡2 LC|n 2008037451 | ||
996 | ‡2 ISNI|0000000029190144 | ||
996 | ‡2 LC|no 97057734 | ||
996 | ‡2 ISNI|0000000387924785 | ||
996 | ‡2 LC|n 2017064030 | ||
996 | ‡2 LC|n 86007830 | ||
996 | ‡2 DNB|1194885063 | ||
996 | ‡2 CYT|AC000643970 | ||
996 | ‡2 NUKAT|n 2015125946 | ||
996 | ‡2 LC|no2009155602 | ||
996 | ‡2 DNB|1019705787 | ||
996 | ‡2 LC|n 2007033629 | ||
996 | ‡2 LC|n 80045685 | ||
996 | ‡2 ISNI|0000000468128238 | ||
996 | ‡2 DNB|1211279693 | ||
996 | ‡2 CYT|AC000264596 | ||
996 | ‡2 DNB|1177172585 | ||
996 | ‡2 LC|nr2001023225 | ||
996 | ‡2 LC|n 80068808 | ||
996 | ‡2 ISNI|0000000083195587 | ||
996 | ‡2 ISNI|0000000088277346 | ||
996 | ‡2 ISNI|0000000452089051 | ||
996 | ‡2 ISNI|000000011251105X | ||
996 | ‡2 BNF|17128031 | ||
996 | ‡2 ISNI|0000000063458060 | ||
996 | ‡2 PLWABN|9812692453005606 | ||
996 | ‡2 DBC|87097947422574 | ||
996 | ‡2 BNF|17721847 | ||
996 | ‡2 ISNI|0000000109559757 | ||
996 | ‡2 ISNI|0000000063388146 | ||
996 | ‡2 ISNI|000000036037797X | ||
996 | ‡2 LC|n 2007032760 | ||
996 | ‡2 NTA|140557016 | ||
996 | ‡2 SUDOC|035625198 | ||
996 | ‡2 NII|DA02510369 | ||
996 | ‡2 LC|n 85333952 | ||
996 | ‡2 LC|n 85114118 | ||
996 | ‡2 NUKAT|n 2009166066 | ||
996 | ‡2 ISNI|0000000063715127 | ||
996 | ‡2 LC|n 80027761 | ||
996 | ‡2 CYT|AC000400833 | ||
996 | ‡2 LC|n 2010184950 | ||
996 | ‡2 CYT|AC000375903 | ||
996 | ‡2 LC|nr 96020811 | ||
996 | ‡2 ISNI|0000000063868473 | ||
996 | ‡2 LC|n 85236556 | ||
996 | ‡2 CAOONL|ncf10506730 | ||
996 | ‡2 ISNI|0000000063478483 | ||
996 | ‡2 LC|nr 97016119 | ||
996 | ‡2 NUKAT|n 2017173691 | ||
996 | ‡2 DNB|1175011096 | ||
996 | ‡2 ISNI|0000000043548659 | ||
996 | ‡2 LC|no2013124484 | ||
996 | ‡2 ISNI|0000000063382457 | ||
996 | ‡2 CYT|AC000127642 | ||
996 | ‡2 CYT|AC000210016 | ||
996 | ‡2 SUDOC|116518022 | ||
996 | ‡2 SUDOC|171627687 | ||
996 | ‡2 LC|n 89125506 | ||
996 | ‡2 LC|n 2016035519 | ||
996 | ‡2 BNF|17119812 | ||
996 | ‡2 CYT|AC000650292 | ||
996 | ‡2 ISNI|0000000040629525 | ||
996 | ‡2 ISNI|0000000391011946 | ||
996 | ‡2 ISNI|0000000063808294 | ||
996 | ‡2 BIBSYS|90270020 | ||
996 | ‡2 CYT|AC000640718 | ||
996 | ‡2 CAOONL|ncf13724084 | ||
996 | ‡2 ISNI|0000000053539238 | ||
996 | ‡2 DNB|1206811447 | ||
996 | ‡2 DNB|1141796457 | ||
996 | ‡2 NII|DA18230929 | ||
996 | ‡2 BNF|12563436 | ||
996 | ‡2 LC|no2021092437 | ||
996 | ‡2 PTBNP|1881247 | ||
996 | ‡2 NUKAT|n 00043767 | ||
996 | ‡2 NTA|14619909X | ||
996 | ‡2 LC|nb2008001001 | ||
996 | ‡2 CYT|AC000065375 | ||
996 | ‡2 NII|DA10439270 | ||
996 | ‡2 LC|no2011100743 | ||
996 | ‡2 BNF|18131907 | ||
996 | ‡2 LC|no2020102836 | ||
996 | ‡2 PLWABN|9810578850605606 | ||
996 | ‡2 DNB|127142851 | ||
996 | ‡2 CYT|AC000154066 | ||
996 | ‡2 PLWABN|9813130640605606 | ||
996 | ‡2 ISNI|0000000081336630 | ||
996 | ‡2 ISNI|0000000116701811 | ||
996 | ‡2 NKC|jo2017969683 | ||
996 | ‡2 LC|n 2005030305 | ||
996 | ‡2 CYT|AC000641539 | ||
996 | ‡2 LC|no2012113896 | ||
996 | ‡2 DNB|1341253341 | ||
996 | ‡2 DNB|133268212X | ||
996 | ‡2 LC|no2020084562 | ||
996 | ‡2 CYT|AC000647386 | ||
996 | ‡2 DNB|1268542172 | ||
996 | ‡2 LC|no2013024479 | ||
996 | ‡2 CYT|AC000259539 | ||
996 | ‡2 DNB|1210082403 | ||
996 | ‡2 LC|nr 92025778 | ||
996 | ‡2 J9U|987007348229805171 | ||
996 | ‡2 LC|n 2005208899 | ||
996 | ‡2 ISNI|000000012136627X | ||
996 | ‡2 DNB|1232652024 | ||
996 | ‡2 LC|n 99010980 | ||
996 | ‡2 CYT|AC000587271 | ||
996 | ‡2 LC|n 2020007695 | ||
996 | ‡2 DNB|142673153 | ||
996 | ‡2 DNB|1331345650 | ||
996 | ‡2 CAOONL|ncf10143662 | ||
996 | ‡2 SUDOC|159739705 | ||
996 | ‡2 CYT|AC000641994 | ||
996 | ‡2 LC|no2010020696 | ||
996 | ‡2 LC|n 2017022691 | ||
996 | ‡2 LC|n 2008037023 | ||
996 | ‡2 LC|n 2002060364 | ||
996 | ‡2 LC|n 2013009383 | ||
996 | ‡2 DNB|1153934957 | ||
996 | ‡2 LC|no2005120071 | ||
996 | ‡2 NTA|22746107X | ||
996 | ‡2 LC|no2009073686 | ||
996 | ‡2 LC|n 87873038 | ||
996 | ‡2 LC|n 2014067287 | ||
996 | ‡2 LC|no2006136731 | ||
996 | ‡2 BIBSYS|13070357 | ||
996 | ‡2 CAOONL|ncf11217068 | ||
996 | ‡2 LC|n 2020049582 | ||
996 | ‡2 LC|no2013060026 | ||
996 | ‡2 CYT|AC000160552 | ||
996 | ‡2 ISNI|000000044242395X | ||
996 | ‡2 LC|n 85306108 | ||
996 | ‡2 ISNI|0000000064225111 | ||
996 | ‡2 CYT|AC000161034 | ||
996 | ‡2 DNB|1029449597 | ||
996 | ‡2 BNF|18103640 | ||
996 | ‡2 DNB|1192691644 | ||
996 | ‡2 ISNI|0000000063967076 | ||
996 | ‡2 CYT|AC000160520 | ||
996 | ‡2 ISNI|0000000390709613 | ||
996 | ‡2 LC|nr 97041279 | ||
996 | ‡2 NTA|422871494 | ||
996 | ‡2 SUDOC|231703864 | ||
996 | ‡2 ISNI|0000000077698663 | ||
996 | ‡2 DNB|1256850365 | ||
996 | ‡2 LC|n 2005070277 | ||
996 | ‡2 NII|DA11676715 | ||
996 | ‡2 J9U|987007412649105171 | ||
996 | ‡2 ISNI|0000000063674038 | ||
996 | ‡2 LC|no 00087480 | ||
996 | ‡2 NLR|RU NLR AUTH 770151345 | ||
996 | ‡2 LC|nr 95017219 | ||
996 | ‡2 LC|no2009032114 | ||
996 | ‡2 LC|n 2013064683 | ||
996 | ‡2 LC|nb2009029128 | ||
996 | ‡2 DNB|1230085025 | ||
996 | ‡2 LC|n 2015014550 | ||
996 | ‡2 NTA|14208848X | ||
996 | ‡2 DNB|1061987582 | ||
996 | ‡2 RERO|A020263869 | ||
996 | ‡2 DNB|1206812648 | ||
996 | ‡2 LC|n 87928964 | ||
996 | ‡2 CYT|AC000160452 | ||
996 | ‡2 DNB|129406708 | ||
996 | ‡2 NTA|148367682 | ||
996 | ‡2 DNB|133989925 | ||
996 | ‡2 LC|n 2008083648 | ||
996 | ‡2 LC|n 78047007 | ||
996 | ‡2 DNB|136409342 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |